Top

Open Access 28-11-2024 | Review

Frontal Fibrosing Alopecia: A Comprehensive Guide for Cosmetic Dermatologists

Authors: Marina Landau, Sofia M. Perez, Antonella Tosti

Abstract

Frontal fibrosing alopecia (FFA) is an inflammatory, scarring hair loss that commonly affects postmenopausal women and presents as frontal hairline recession, facial papules, loss of eyebrows, and facial hyperpigmentation. Because of the chronic, progressive nature of this disease and its important impact on aesthetic appearance, patients often consult dermatologists to improve unwanted FFA symptoms. Cosmetic practices including the use of non-ablative lasers, autologous fat injections, and oral isotretinoin can improve FFA-associated facial vein prominence, atrophic indentations, and facial papules, respectively. On the other hand, while exact etiology underlying FFA development remains unclear, some procedures including deep chemical peels and ablative laser therapies have been shown to induce facial scarring and are contraindicated in patients with FFA. In the same way, some cosmetic ingredients can possibly be a triggering or worsening factor for FFA as well. Therefore, it is essential for dermatologists to be aware of both the benefits and risks of cosmetic treatments in patients with diagnosed or suspected FFA. This comprehensive review aims to outline the key cosmetic products and procedures that may be useful in patients with FFA and those which should be considered contraindicated.

Vano-Galvan S, Molina-Ruiz AM, Serrano-Falcon C, et al. Frontal fibrosing alopecia: a multicenter review of 355 patients. J Am Acad Dermatol. 2014;70(4):670–8. https://doi.org/10.1016/j.jaad.2013.12.003.CrossRefPubMed

Senna MM, Peterson E, Jozic I, Cheret J, Paus R. Frontiers in lichen planopilaris and frontal fibrosing alopecia research: pathobiology progress and translational horizons. JID Innov. 2022;2(3):100113. https://doi.org/10.1016/j.xjidi.2022.100113.CrossRefPubMedPubMedCentral

Krzeslowska WJ, Wozniacka A. The frontal fibrosing alopecia treatment dilemma. J Clin Med. 2024;13(7):2137. https://doi.org/10.3390/jcm13072137.CrossRefPubMedPubMedCentral

Donati A, Molina L, Doche I, Valente NS, Romiti R. Facial papules in frontal fibrosing alopecia: evidence of vellus follicle involvement. Arch Dermatol. 2011;147(12):1424–7. https://doi.org/10.1001/archdermatol.2011.321.CrossRefPubMed

Fernandez-Crehuet P, Rodrigues-Barata AR, Vano-Galvan S, et al. Trichoscopic features of frontal fibrosing alopecia: results in 249 patients. J Am Acad Dermatol. 2015;72(2):357–9. https://doi.org/10.1016/j.jaad.2014.10.039.CrossRefPubMed

Starace M, Cedirian S, Rapparini L, et al. Enhanced insights into frontal fibrosing alopecia: advancements in pathogenesis understanding and management strategies. Dermatol Ther (Heidelb). 2024;14(6):1457–77. https://doi.org/10.1007/s13555-024-01186-0.CrossRefPubMedPubMedCentral

Trager MH, Lavian J, Lee EY, et al. Prevalence estimates for lichen planopilaris and frontal fibrosing alopecia in a New York City health care system. J Am Acad Dermatol. 2021;84(4):1166–9. https://doi.org/10.1016/j.jaad.2020.10.081.CrossRefPubMed

Vano-Galvan S, Saceda-Corralo D, Blume-Peytavi U, et al. Frequency of the types of alopecia at twenty-two specialist hair clinics: a multicenter study. Skin Appendage Disord. 2019;5(5):309–15. https://doi.org/10.1159/000496708.CrossRefPubMedPubMedCentral

Mirmirani P, Tosti A, Goldberg L, Whiting D, Sotoodian B. Frontal fibrosing alopecia: an emerging epidemic. Skin Appendage Disord. 2019;5(2):90–3. https://doi.org/10.1159/000489793.CrossRefPubMed

10.

Lee YB, Shin MK, Kim JS, et al. Perceptions and behavior regarding skin health and skin care products: analysis of the questionnaires for the visitors of skin health expo 2018. Ann Dermatol. 2020;32(5):375–82. https://doi.org/10.5021/ad.2020.32.5.375.CrossRefPubMedPubMedCentral

11.

Cranwell WC, Sinclair R. Sunscreen and facial skincare products in frontal fibrosing alopecia: a case-control study. Br J Dermatol. 2019;180(4):943–4. https://doi.org/10.1111/bjd.17354.CrossRefPubMed

12.

Debroy Kidambi A, Dobson K, Holmes S, et al. Frontal fibrosing alopecia in men: an association with facial moisturizers and sunscreens. Br J Dermatol. 2017;177(1):260–1. https://doi.org/10.1111/bjd.15311.CrossRefPubMed

13.

Pham CT, Juhasz M, Ekelem C, et al. The association of frontal alopecia with a history of facial and scalp surgical procedures. Skin Appendage Disord. 2022;8(1):13–9. https://doi.org/10.1159/000518156.CrossRefPubMed

14.

Landau M, Tosti A, Kroumpouzos G, Eims E, Goldust M. Frontal fibrosing alopecia—a new absolute contraindication for deep chemical peels. Clin Dermatol. 2024. https://doi.org/10.1016/j.clindermatol.2024.06.024.CrossRefPubMed

15.

Sun C, Lim D, Bekhor P. Extensive facial scarring after ablative laser resurfacing in a patient with frontal fibrosing alopecia. JAAD Case Rep. 2022;23:123–7. https://doi.org/10.1016/j.jdcr.2022.03.024.CrossRefPubMedPubMedCentral

16.

Cook MK, Perche PO, White JC, Feldman SR, Strowd LC. Psychosocial burden of frontal fibrosing alopecia: a qualitative interview study. Br J Dermatol. 2022;187(6):1013–5. https://doi.org/10.1111/bjd.21786.CrossRefPubMed

17.

Sun L, Mehrabi S, Khetarpal S, Piliang M. Characterization and treatment of prominent facial vasculature in the setting of frontal fibrosing alopecia. J Am Acad Dermatol. 2023;88(1):174–6. https://doi.org/10.1016/j.jaad.2021.12.051.CrossRefPubMed

18.

Sadeghi S, Ghane Y, Hajizadeh N, Goodarzi A. Autologous adipose tissue injection in the treatment of alopecia: a mini-review. J Cosmet Dermatol. 2024;23(3):758–65. https://doi.org/10.1111/jocd.16081.CrossRefPubMed

19.

Orringer JS, Rittie L, Baker D, Voorhees JJ, Fisher G. Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol. 2010;163(4):757–68. https://doi.org/10.1111/j.1365-2133.2010.09998.x.CrossRefPubMed

20.

Alexiades-Armenakas MR, Dover JS, Arndt KA. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol. 2008;58(5):719–37. https://doi.org/10.1016/j.jaad.2008.01.003. (Quiz 738-40).CrossRefPubMed

21.

Lin J, Valdebran M, Bergfeld W, Conic RZ, Piliang M, Atanaskova MN. Hypopigmentation in frontal fibrosing alopecia. J Am Acad Dermatol. 2017;76(6):1184–6. https://doi.org/10.1016/j.jaad.2017.01.001.CrossRefPubMed

22.

Tosti A, Piraccini BM, Iorizzo M, Misciali C. Frontal fibrosing alopecia in postmenopausal women. J Am Acad Dermatol. 2005;52(1):55–60. https://doi.org/10.1016/j.jaad.2004.05.014.CrossRefPubMed

23.

Subash J, Eginli A, Bomar L, McMichael A. Frontal fibrosing alopecia treatment with Nd:YAG (1064 nm) nonablative laser. Int J Womens Dermatol. 2021;7(3):355–6. https://doi.org/10.1016/j.ijwd.2020.10.007.CrossRefPubMed

24.

Saceda-Corralo D, Moreno-Arrones OM, Fonda-Pascual P, et al. Steroid-induced changes noted on trichoscopy of patients with frontal fibrosing alopecia. J Am Acad Dermatol. 2018;79(5):956–7. https://doi.org/10.1016/j.jaad.2018.05.001.CrossRefPubMed

25.

Vano-Galvan S, Rodrigues-Barata AR, Urech M, et al. Depression of the frontal veins: a new clinical sign of frontal fibrosing alopecia. J Am Acad Dermatol. 2015;72(6):1087–8. https://doi.org/10.1016/j.jaad.2015.02.1129.CrossRefPubMed

26.

Bala L, Tsang C, Agarwal V, Elshimy N. P103 Clinical clues for frontal fibrosing alopecia: a case series describing prominent, depressed forehead veins. Br J Dermatol. 2024;191(Supplement_1):i64–5. https://doi.org/10.1093/bjd/ljae090.130.CrossRef

27.

Xavier de Brito FO, Cortez de Almeida RF, Machado CJ, et al. Frontal fibrosing alopecia associated with lichen planus pigmentosus: a multicentre retrospective descriptive analytical study of 104 patients. J Eur Acad Dermatol Venereol. 2023. https://doi.org/10.1111/jdv.19093.CrossRefPubMed

28.

Fonda-Pascual P, Moreno-Arrones OM, Saceda-Corralo D, et al. Effectiveness of low-level laser therapy in lichen planopilaris. J Am Acad Dermatol. 2018;78(5):1020–3. https://doi.org/10.1016/j.jaad.2017.11.040.CrossRefPubMed

29.

Navarini AA, Kolios AG, Prinz-Vavricka BM, Haug S, Trueb RM. Low-dose excimer 308-nm laser for treatment of lichen planopilaris. Arch Dermatol. 2011;147(11):1325–6. https://doi.org/10.1001/archdermatol.2011.335.CrossRefPubMed

30.

Randolph MJ, Salhi WA, Tosti A. Lichen planopilaris and low-level light therapy: four case reports and review of the literature about low-level light therapy and lichenoid dermatosis. Dermatol Ther (Heidelb). 2020;10(2):311–9. https://doi.org/10.1007/s13555-020-00359-x.CrossRefPubMed

31.

Gerkowicz A, Bartosinska J, Wolska-Gawron K, Michalska-Jakubus M, Kwasny M, Krasowska D. Application of superluminescent diodes (sLED) in the treatment of scarring alopecia—a pilot study. Photodiagn Photodyn Ther. 2019;28:195–200. https://doi.org/10.1016/j.pdpdt.2019.09.006.CrossRef

32.

Perez SM, Vattigunta M, Kelly C, Eber A. Low-level laser and LED therapy in alopecia: a systematic review and meta-analysis. Dermatol Surg. 2024. https://doi.org/10.1097/DSS.0000000000004442.CrossRefPubMed

33.

Gerkowicz A, Bartosinska J, Raczkiewicz D, Kwasny M, Krasowska D. Novel application of light-emitting diode therapy in the treatment of eyebrow loss in frontal fibrosing alopecia. Sensors (Basel). 2021;21(17):5981. https://doi.org/10.3390/s21175981.CrossRefPubMed

34.

Nguyen B, Hu JK, Tosti A. Eyebrow and eyelash alopecia: a clinical review. Am J Clin Dermatol. 2023;24(1):55–67. https://doi.org/10.1007/s40257-022-00729-5.CrossRefPubMed

35.

Liu Y, Mao R, Xiao M, Zhu W, Liu Y, Xiao H. Facial rejuvenation: a global trend of dermatological procedures in the last decade. Plast Reconstr Surg Glob Open. 2024;12(6):e5801. https://doi.org/10.1097/GOX.0000000000005801.CrossRefPubMedPubMedCentral

36.

Gan SD, Itkin A, Wolpowitz D. Hyaluronic acid-induced alopecia: a novel complication. Dermatol Surg. 2013;39(11):1724–5. https://doi.org/10.1111/dsu.12333.CrossRefPubMed

37.

Yang Q, Qiu L, Yi C, et al. Reversible alopecia with localized scalp necrosis after accidental embolization of the parietal artery with hyaluronic acid. Aesthetic Plast Surg. 2017;41(3):695–9. https://doi.org/10.1007/s00266-017-0841-z.CrossRefPubMed

38.

Khunkhet S, Rattananukrom T, Thanasarnaksorn W, Suchonwanit P. Alopecia induced by autologous fat injection into the temporal area: case report and review of the literature. Case Rep Dermatol. 2019;11(2):150–6. https://doi.org/10.1159/000500710.CrossRefPubMedPubMedCentral

39.

Pulumati A, Algarin Y, Jaalouk D, Latta S, Nouri K. Fillers impacting follicles: the emerging complication of filler-induced alopecia. Int J Dermatol. 2024;63(9):1131–9. https://doi.org/10.1111/ijd.17169.CrossRefPubMed

40.

Siperstein R, Nestor E, Meran S. Prospective clinical trial demonstrating the efficacy of hyaluronic acid filler for the improvement of atrophic facial scars up to 2 years. Dermatol Surg. 2024. https://doi.org/10.1097/DSS.0000000000004315.CrossRefPubMedPubMedCentral

41.

Siperstein R, Nestor E, Meran S, Grunebaum L. A split-face, blind, randomized placebo-controlled clinical trial investigating the efficacy and safety of hyaluronic acid filler for the correction of atrophic facial scars. J Cosmet Dermatol. 2022;21(9):3768–78. https://doi.org/10.1111/jocd.15153.CrossRefPubMedPubMedCentral

42.

Barklund S, Brown M. Treatment of steroid atrophy with hyaluronic acid filler. JAAD Case Rep. 2020;6(10):973–4. https://doi.org/10.1016/j.jdcr.2020.07.031.CrossRefPubMedPubMedCentral

43.

Harries MJ, Wong S, Farrant P. Frontal fibrosing alopecia and increased scalp sweating: is neurogenic inflammation the common link? Skin Appendage Disord. 2016;1(4):179–84. https://doi.org/10.1159/000444758.CrossRefPubMedPubMedCentral

44.

Hussein RS, Dayel SB, Abahussein O. Botulinum toxin A for hair loss treatment: a systematic review of efficacy, safety, and future directions. JPRAS Open. 2023;38:296–304. https://doi.org/10.1016/j.jpra.2023.09.006.CrossRefPubMedPubMedCentral

45.

Nguyen B, Perez SM, Tosti A. Botulinum toxin for scalp conditions: a systematic review. Dermatol Surg. 2023;49(11):1023–6. https://doi.org/10.1097/DSS.0000000000003895.CrossRefPubMed

46.

Di Pietro A, Piraccini BM. Frontal alopecia after repeated botulinum toxin type a injections for forehead wrinkles: an underestimated entity? Skin Appendage Disord. 2016;2(1–2):67–9. https://doi.org/10.1159/000448380.CrossRefPubMedPubMedCentral

47.

Almeida MAD, Reis-Feroldi MM, Lira MLA. Frontal fibrosing alopecia development in two patients after botulinum toxin applications: relationship or coincidence? Surg Cosmet Dermatol. 2021. https://doi.org/10.5935/scd1984-8773.2021130036.CrossRef

48.

Donovan JC. Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia. JAAD Case Rep. 2015;1(6):353–5. https://doi.org/10.1016/j.jdcr.2015.08.003.CrossRefPubMedPubMedCentral

49.

Nilforoushzadeh MA, Heidari-Kharaji M, Baiat Tork B, et al. The first study on autologous adipose tissue transfer in the treatment of lichen planopilaris. J Cosmet Dermatol. 2022;21(10):5295–7. https://doi.org/10.1111/jocd.15037.CrossRefPubMed

50.

Cho SB, Roh MR, Chung KY. Recovery of scleroderma-induced atrophic alopecia by autologous fat transplantation. Dermatol Surg. 2010;36(12):2061–3. https://doi.org/10.1111/j.1524-4725.2010.01783.x.CrossRefPubMed

51.

Dini M, Mori A, Quattrini LA. Eyebrow regrowth in patient with atrophic scarring alopecia treated with an autologous fat graft. Dermatol Surg. 2014;40(8):926–8. https://doi.org/10.1111/DSU.0000000000000051.CrossRefPubMed

52.

Nanda S, Chauhan K, Shetty V, Dashore S, Bhatia S. Platelet-rich plasma in aesthetics. Indian Dermatol Online J. 2021;12(Suppl 1):S41–54. https://doi.org/10.4103/idoj.idoj_290_21.CrossRefPubMedPubMedCentral

53.

Alam M, Hughart R, Champlain A, et al. Effect of platelet-rich plasma injection for rejuvenation of photoaged facial skin: a randomized clinical trial. JAMA Dermatol. 2018;154(12):1447–52. https://doi.org/10.1001/jamadermatol.2018.3977.CrossRefPubMedPubMedCentral

54.

Elnehrawy NY, Ibrahim ZA, Eltoukhy AM, Nagy HM. Assessment of the efficacy and safety of single platelet-rich plasma injection on different types and grades of facial wrinkles. J Cosmet Dermatol. 2017;16(1):103–11. https://doi.org/10.1111/jocd.12258.CrossRefPubMed

55.

Hesseler MJ, Shyam N. Platelet-rich plasma and its utility in the treatment of acne scars: a systematic review. J Am Acad Dermatol. 2019;80(6):1730–45. https://doi.org/10.1016/j.jaad.2018.11.029.CrossRefPubMed

56.

Hooper D. Platelet-rich plasma has a place in the treatment of androgenetic alopecia. J Am Acad Dermatol. 2021;84(4):1186–7. https://doi.org/10.1016/j.jaad.2020.11.030.CrossRefPubMed

57.

Bolanca Z, Goren A, Getaldic-Svarc B, Vucic M, Situm M. Platelet-rich plasma as a novel treatment for lichen planopillaris. Dermatol Ther. 2016;29(4):233–5. https://doi.org/10.1111/dth.12343.CrossRefPubMed

58.

Jha AK. Platelet-rich plasma as an adjunctive treatment in lichen planopilaris. J Am Acad Dermatol. 2019;80(5):e109–10. https://doi.org/10.1016/j.jaad.2018.09.013.CrossRefPubMed

59.

Alves R, Grimalt R. Platelet-rich plasma and its use for cicatricial and non-cicatricial alopecias: a narrative review. Dermatol Ther (Heidelb). 2020;10(4):623–33. https://doi.org/10.1007/s13555-020-00408-5.CrossRefPubMed

60.

Ozcan D, Tuncer Vural A, Ozen O. Platelet-rich plasma for treatment resistant frontal fibrosing alopecia: a case report. Dermatol Ther. 2019;32(5):e13072. https://doi.org/10.1111/dth.13072.CrossRefPubMed

61.

Finney R. Commentary on use of platelet-rich plasma in cicatricial alopecia. Dermatol Surg. 2019;45(7):982–3. https://doi.org/10.1097/DSS.0000000000001618.CrossRefPubMed

62.

Beyzaee AM, Babaei M, Ghoreishi B, et al. Isotretinoin as a promising option in the treatment of facial papules of frontal fibrosing alopecia. Int J Dermatol. 2024. https://doi.org/10.1111/ijd.17356.CrossRefPubMed

63.

Pedrosa AF, Duarte AF, Haneke E, Correia O. Yellow facial papules associated with frontal fibrosing alopecia: a distinct histologic pattern and response to isotretinoin. J Am Acad Dermatol. 2017;77(4):764–6. https://doi.org/10.1016/j.jaad.2017.04.1118.CrossRefPubMed

64.

Pirmez R, Duque-Estrada B, Barreto T, Quintella DC, Cuzzi T. Successful treatment of facial papules in frontal fibrosing alopecia with oral isotretinoin. Skin Appendage Disord. 2017;3(2):111–3. https://doi.org/10.1159/000464334.CrossRefPubMedPubMedCentral

65.

Flores-Terry MA, Garcia-Arpa M, Franco-Munoz M, Gonzalez-Ruiz L. Facial papules in frontal fibrosing alopecia: good response to isotretinoin [Papulas faciales en alopecia frontal fibrosante con buena respuesta a isotretinoina]. Actas Dermosifiliogr (Engl Ed). 2018;109(9):831–3. https://doi.org/10.1016/j.ad.2017.08.018.CrossRefPubMed

66.

Morgado-Carrasco D, Fusta-Novell X. Frontal fibrosing alopecia. JAMA Dermatol. 2020;156(1):92. https://doi.org/10.1001/jamadermatol.2019.3110.CrossRefPubMed

67.

Babahosseini H, Tavakolpour S, Mahmoudi H, et al. Lichen planopilaris: retrospective study on the characteristics and treatment of 291 patients. J Dermatol Treat. 2019;30(6):598–604. https://doi.org/10.1080/09546634.2018.1542480.CrossRef

68.

Mahmoudi H, Rostami A, Tavakolpour S, et al. Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial. J Dermatol Treat. 2022;33(1):284–90. https://doi.org/10.1080/09546634.2020.1750553.CrossRef

69.

Campbell V, McKenna K. Facial papules of frontal fibrosing alopecia—response to oral isotretinoin. Dermatol Ther. 2020;33(6):e14274. https://doi.org/10.1111/dth.14274.CrossRefPubMed

70.

Fatemi F, Mohaghegh F, Danesh F, Saber M, Rajabi P. Isotretinoin for the treatment of facial lichen planopilaris: a new indication for an old drug, a case series study. Clin Case Rep. 2020;8(12):2524–9. https://doi.org/10.1002/ccr3.3210.CrossRefPubMedPubMedCentral

71.

Pham CT, Hosking AM, Cox S, Mesinkovska NA. Therapeutic response of facial papules and inflammation in frontal fibrosing alopecia to low-dose oral isotretinoin. JAAD Case Rep. 2020;6(5):453–6. https://doi.org/10.1016/j.jdcr.2020.01.030.CrossRefPubMedPubMedCentral

72.

Saber M, Bahraminejad M, Fatemi Naeini F, Mohaghegh F, Faghihi G, Hosseini SM. Comparison of systemic and topical isotretinoin in the treatment of facial lichen planopilaris: a randomized controlled trial. J Cosmet Dermatol. 2022;21(9):3896–904. https://doi.org/10.1111/jocd.14730.CrossRefPubMed

73.

Rokni GR, Emadi SN, Dabbaghzade A, et al. Evaluating the combined efficacy of oral isotretinoin and topical tacrolimus versus oral finasteride and topical tacrolimus in frontal fibrosing alopecia—a randomized controlled trial. J Cosmet Dermatol. 2023;22(2):613–9. https://doi.org/10.1111/jocd.15232.CrossRefPubMed

74.

Lee JY, Hong JS, Lee SH, Lee AY. Successful treatment of frontal fibrosing alopecia with alitretinoin. Dermatol Ther. 2019;32(5):e13037. https://doi.org/10.1111/dth.13037.CrossRefPubMed

75.

Gamret AC, Potluri VS, Krishnamurthy K, Fertig RM. Frontal fibrosing alopecia: efficacy of treatment modalities. Int J Womens Health. 2019;11:273–85. https://doi.org/10.2147/IJWH.S177308.CrossRefPubMedPubMedCentral

76.

Rakowska A, Gradzinska A, Olszewska M, Rudnicka L. Efficacy of isotretinoin and acitretin in treatment of frontal fibrosing alopecia: retrospective analysis of 54 cases. J Drugs Dermatol. 2017;16(10):988–92.PubMed

77.

Tan KT, Messenger AG. Frontal fibrosing alopecia: clinical presentations and prognosis. Br J Dermatol. 2009;160(1):75–9. https://doi.org/10.1111/j.1365-2133.2008.08861.x.CrossRefPubMed

78.

Modena DAO, Miranda ACG, Grecco C, Liebano RE, Cordeiro RCT, Guidi RM. Efficacy, safety, and guidelines of application of the fractional ablative laser erbium YAG 2940 nm and non-ablative laser erbium glass in rejuvenation, skin spots, and acne in different skin phototypes: a systematic review. Lasers Med Sci. 2020;35(9):1877–88. https://doi.org/10.1007/s10103-020-03046-7.CrossRefPubMed

79.

Plikus MV, Gay DL, Treffeisen E, Wang A, Supapannachart RJ, Cotsarelis G. Epithelial stem cells and implications for wound repair. Semin Cell Dev Biol. 2012;23(9):946–53. https://doi.org/10.1016/j.semcdb.2012.10.001.CrossRefPubMedPubMedCentral

80.

Landau M, Bageorgeou F. Update on chemical peels. Dermatol Clin. 2024;42(1):13–20. https://doi.org/10.1016/j.det.2023.06.005.CrossRefPubMed

81.

Wambier CG, Lee KC, Soon SL, et al. Advanced chemical peels: phenol-croton oil peel. J Am Acad Dermatol. 2019;81(2):327–36. https://doi.org/10.1016/j.jaad.2018.11.060.CrossRefPubMed

82.

Ohyama M. Hair follicle bulge: a fascinating reservoir of epithelial stem cells. J Dermatol Sci. 2007;46(2):81–9. https://doi.org/10.1016/j.jdermsci.2006.12.002.CrossRefPubMed

83.

Vanscheidt W, Hunziker T. Repigmentation by outer-root-sheath-derived melanocytes: proof of concept in vitiligo and leucoderma. Dermatology. 2009;218(4):342–3. https://doi.org/10.1159/000197467.CrossRefPubMed

84.

Diaz AA, Miteva M. Peripilar, “guttate” hypopigmentation of the scalp and idiopathic guttate hypomelanosis in frontal fibrosing alopecia. Skin Appendage Disord. 2019;5(2):100–3. https://doi.org/10.1159/000489794.CrossRefPubMed

85.

Paiva ML, Justo AS, Lemes BM, et al. Skin of color repigmentation after phenol-croton oil chemical peel. J Am Acad Dermatol. 2023;89(5):1068–70. https://doi.org/10.1016/j.jaad.2023.06.053.CrossRefPubMed

86.

Kossard S, Shiell RC. Frontal fibrosing alopecia developing after hair transplantation for androgenetic alopecia. Int J Dermatol. 2005;44(4):321–3. https://doi.org/10.1111/j.1365-4632.2004.02251.x.CrossRefPubMed

87.

Chiang YZ, Tosti A, Chaudhry IH, et al. Lichen planopilaris following hair transplantation and face-lift surgery. Br J Dermatol. 2012;166(3):666–370. https://doi.org/10.1111/j.1365-2133.2011.10692.x.CrossRefPubMed

88.

Taguti P, Dutra H, Trueb RM. Lichen planopilaris caused by wig attachment: a case of koebner phenomenon in frontal fibrosing alopecia. Int J Trichol. 2018;10(4):172–4. https://doi.org/10.4103/ijt.ijt_48_18.CrossRef

89.

Donovan J. Lichen planopilaris after hair transplantation: report of 17 cases. Dermatol Surg. 2012;38(12):1998–2004. https://doi.org/10.1111/dsu.12014.CrossRefPubMed

90.

Crisostomo MR, Crisostomo MC, Crisostomo MG, Gondim VJ, Crisostomo MR, Benevides AN. Hair loss due to lichen planopilaris after hair transplantation: a report of two cases and a literature review. An Bras Dermatol Mar-Apr. 2011;86(2):359–62. https://doi.org/10.1590/s0365-05962011000200024.CrossRef

91.

Vano-Galvan S, Villodres E, Pigem R, et al. Hair transplant in frontal fibrosing alopecia: a multicenter review of 51 patients. J Am Acad Dermatol. 2019;81(3):865–6. https://doi.org/10.1016/j.jaad.2019.05.031.CrossRefPubMed

92.

Jimenez F, Poblet E. Is hair transplantation indicated in frontal fibrosing alopecia? The results of test grafting in three patients. Dermatol Surg. 2013;39(7):1115–8. https://doi.org/10.1111/dsu.12232.CrossRefPubMed

93.

Audickaite A, Alam M, Jimenez F. Eyebrow hair transplantation in frontal fibrosing alopecia: pitfalls of short- and long-term results. Dermatol Surg. 2020;46(7):922–5. https://doi.org/10.1097/DSS.0000000000002207.CrossRefPubMed

94.

Scribel M, Dutra H, Trueb RM. Autologous hair transplantation in frontal fibrosing alopecia. Int J Trichol. 2018;10(4):169–71. https://doi.org/10.4103/ijt.ijt_37_18.CrossRef

95.

El-Domyati M, Moftah NH, Ahmed AM, Ibrahim MR. Evaluation of microneedling depth of penetration in management of atrophic acne scars: a split-face comparative study. Int J Dermatol. 2024;63(5):632–8. https://doi.org/10.1111/ijd.17006.CrossRefPubMed

96.

Singh A, Yadav S. Microneedling: advances and widening horizons. Indian Dermatol Online J. 2016;7(4):244–54. https://doi.org/10.4103/2229-5178.185468.CrossRefPubMedPubMedCentral

97.

Ziaeifar E, Ziaeifar F, Mozafarpoor S, Goodarzi A. Applications of microneedling for various dermatologic indications with a special focus on pigmentary disorders: a comprehensive review study. Dermatol Ther. 2021;34(6):e15159. https://doi.org/10.1111/dth.15159.CrossRefPubMed

98.

Alster TS, Graham PM. Microneedling: a review and practical guide. Dermatol Surg. 2018;44(3):397–404. https://doi.org/10.1097/DSS.0000000000001248.CrossRefPubMed

99.

Almohanna HM, Perper M, Tosti A. Safety concerns when using novel medications to treat alopecia. Expert Opin Drug Saf. 2018;17(11):1115–28. https://doi.org/10.1080/14740338.2018.1533549.CrossRefPubMed

100.

Zhang X, Lei L, Jiang L, et al. Characteristics and pathogenesis of Koebner phenomenon. Exp Dermatol. 2023;32(4):310–23. https://doi.org/10.1111/exd.14709.CrossRefPubMed

101.

Robinson G, McMichael A, Wang SQ, Lim HW. Sunscreen and frontal fibrosing alopecia: a review. J Am Acad Dermatol. 2020;82(3):723–8. https://doi.org/10.1016/j.jaad.2019.09.085.CrossRefPubMed

102.

Tosti A, Bergfeld WF, Christiano AM, et al. Response from the American Hair Research Society to “Sunscreen and frontal fibrosing alopecia: a review.” J Am Acad Dermatol. 2020;82(3):729–30. https://doi.org/10.1016/j.jaad.2019.10.032.CrossRefPubMed

103.

Maghfour J, Ceresnie M, Olson J, Lim HW. The association between frontal fibrosing alopecia, sunscreen, and moisturizers: a systematic review and meta-analysis. J Am Acad Dermatol. 2022;87(2):395–6. https://doi.org/10.1016/j.jaad.2021.12.058.CrossRefPubMed

104.

Schneider SL, Lim HW. Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol. 2019;80(1):266–71. https://doi.org/10.1016/j.jaad.2018.06.033.CrossRefPubMed

105.

Wang J, Pan L, Wu S, et al. Recent advances on endocrine disrupting effects of UV filters. Int J Environ Res Public Health. 2016;13(8):782. https://doi.org/10.3390/ijerph13080782.CrossRefPubMedPubMedCentral

106.

Phelan-Dickinson SJ, Palmer BC, Chen Y, DeLouise LA. The UVR filter octinoxate modulates aryl hydrocarbon receptor signaling in keratinocytes via inhibition of CYP1A1 and CYP1B1. Toxicol Sci. 2020;177(1):188–201. https://doi.org/10.1093/toxsci/kfaa091.CrossRefPubMedPubMedCentral

107.

Nohynek GJ, Lademann J, Ribaud C, Roberts MS. Grey goo on the skin? Nanotechnology, cosmetic and sunscreen safety. Crit Rev Toxicol. 2007;37(3):251–77. https://doi.org/10.1080/10408440601177780.CrossRefPubMed

108.

Musial J, Krakowiak R, Mlynarczyk DT, Goslinski T, Stanisz BJ. Titanium dioxide nanoparticles in food and personal care products—what do we know about their safety? Nanomaterials (Basel). 2020;10(6):1110. https://doi.org/10.3390/nano10061110.CrossRefPubMed

109.

Lademann J, Weigmann H, Rickmeyer C, et al. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice. Skin Pharmacol Appl Skin Physiol. 1999;12(5):247–56. https://doi.org/10.1159/000066249.CrossRefPubMed

110.

Senzui M, Tamura T, Miura K, Ikarashi Y, Watanabe Y, Fujii M. Study on penetration of titanium dioxide (TiO₂) nanoparticles into intact and damaged skin in vitro. J Toxicol Sci. 2010;35(1):107–13. https://doi.org/10.2131/jts.35.107.CrossRefPubMed

111.

Adachi K, Yamada N, Yoshida Y, Yamamoto O. Subchronic exposure of titanium dioxide nanoparticles to hairless rat skin. Exp Dermatol. 2013;22(4):278–83. https://doi.org/10.1111/exd.12121.CrossRefPubMed

112.

de Nicolas-Ruanes B, Berna-Rico E, Azcarraga-Llobet C, et al. A plausible hypothesis for the clinical pattern of frontal fibrosing alopecia: the persistence of residues of leave-on facial products on hairline and eyebrows. J Cosmet Dermatol. 2024. https://doi.org/10.1111/jocd.16448.CrossRefPubMed

113.

Aerts O, Bracke A, Goossens A, Meuleman V, Lambert J. Titanium dioxide nanoparticles and frontal fibrosing alopecia: cause or consequence? J Eur Acad Dermatol Venereol. 2019;33(1):e45–6. https://doi.org/10.1111/jdv.15161.CrossRefPubMed

114.

Thompson CT, Chen ZQ, Kolivras A, Tosti A. Identification of titanium dioxide on the hair shaft of patients with and without frontal fibrosing alopecia: a pilot study of 20 patients. Br J Dermatol. 2019;181(1):216–7. https://doi.org/10.1111/bjd.17639.CrossRefPubMed

115.

Lyakhovitsky A, Kartvelishvily E, Drousiotis T, Lyakhovitsky K, Baum S, Barzilai A. Hair shaft morphology, elemental composition, and nanoparticles in frontal fibrosing alopecia: a case-control study. Acta Derm Venereol. 2021;101(9):adv00541. https://doi.org/10.2340/00015555-3891.CrossRefPubMed

116.

Bai X, Yan J, Gilchrest BA. Next-generation zinc oxide-based sunscreens: molecular characteristics and advantages. J Investig Dermatol. 2024;144(2):430–434.e1. https://doi.org/10.1016/j.jid.2023.07.020.CrossRefPubMed

117.

Pastor-Nieto MA, Gatica-Ortega ME, Sanchez-Herreros C, Vergara-Sanchez A, Martinez-Mariscal J, De Eusebio-Murillo E. Sensitization to benzyl salicylate and other allergens in patients with frontal fibrosing alopecia. Contact Dermat. 2021;84(6):423–30. https://doi.org/10.1111/cod.13763.CrossRef

118.

Rocha VB, Donati A, Contin LA, et al. Photopatch and patch testing in 63 patients with frontal fibrosing alopecia: a case series. Br J Dermatol. 2018;179(6):1402–3. https://doi.org/10.1111/bjd.16933.CrossRefPubMed

119.

Prasad S, Marks DH, Burns LJ, et al. Patch testing and contact allergen avoidance in patients with lichen planopilaris and/or frontal fibrosing alopecia: a cohort study. J Am Acad Dermatol. 2020;83(2):659–61. https://doi.org/10.1016/j.jaad.2020.01.026.CrossRefPubMed

120.

Cheret J, Bertolini M, Ponce L, et al. Olfactory receptor OR2AT4 regulates human hair growth. Nat Commun. 2018;9(1):3624. https://doi.org/10.1038/s41467-018-05973-0.CrossRefPubMedPubMedCentral

121.

Verma KK, Fenner B, Pham M, Tarbox M. Common contact allergens implicated in frontal fibrosing alopecia found in over-the-counter hair growth serums and solutions. Int J Womens Dermatol. 2024;10(2):e149. https://doi.org/10.1097/JW9.0000000000000149.CrossRefPubMedPubMedCentral

122.

Aldoori N, Dobson K, Holden CR, McDonagh AJ, Harries M, Messenger AG. Frontal fibrosing alopecia: possible association with leave-on facial skin care products and sunscreens; a questionnaire study. Br J Dermatol. 2016;175(4):762–7. https://doi.org/10.1111/bjd.14535.CrossRefPubMed

123.

George SE, Rodriguez I, Adler BL, Yu J. Tangled truths: unraveling the link between frontal fibrosing alopecia and allergic contact dermatitis. Cutis. 2024;113(3):119–22. https://doi.org/10.12788/cutis.0974.CrossRefPubMed

124.

Uter W, Aalto-Korte K, Agner T, et al. The epidemic of methylisothiazolinone contact allergy in Europe: follow-up on changing exposures. J Eur Acad Dermatol Venereol. 2020;34(2):333–9. https://doi.org/10.1111/jdv.15875.CrossRefPubMed

125.

Guarneri F, Corazza M, Stingeni L, et al. Myroxylon pereirae (balsam of Peru): still worth testing? Contact Dermat. 2021;85(3):269–73. https://doi.org/10.1111/cod.13839.CrossRef

126.

Gherardini J, Chéret J, Collins M, Epstein-Kuka G, Paus R, Senna MM. 1406 Environmental pathobiology of frontal fibrosing alopecia (FFA): a link between linalool sensitization and FFA development. J Investig Dermatol. 2023;143(5):S241. https://doi.org/10.1016/j.jid.2023.03.1422.CrossRef

Title: Frontal Fibrosing Alopecia: A Comprehensive Guide for Cosmetic Dermatologists
Authors: Marina Landau
Sofia M. Perez
Antonella Tosti
Publication date: 28-11-2024
Publisher: Springer Healthcare
Published in: Dermatology and Therapy
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI: https://doi.org/10.1007/s13555-024-01311-z

Keynote series | Spotlight on menopause

Menopause
Video Series

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024

Prof. Martha Hickey

Dr. Claudia Barth

Dr. Samar El Khoudary

Developed by: Springer Medicine

Keynote webinar | Spotlight on adolescent vaping

Live
Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET

Prof. Ann McNeill

Dr. Debbie Robson

Benji Horwell

Developed by: Springer Medicine

Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty in Geriatric Patients
On-demand webinar

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft

Prof. Barbara C. van Munster

Prof. Mirko Petrovic

Developed by: Springer Medicine

Watch now

A quick guide to ECGs

Electrocardiography
Training Course

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date.

PD Dr. Carsten W. Israel

Developed by: Springer Medizin

Start the cases

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote series | Spotlight on menopause

Springer Medicine

Abstract

Please log in to get access to this content

Keynote series | Spotlight on menopause

Keynote webinar | Spotlight on adolescent vaping

Keynote webinar | Spotlight on modern management of frailty

A quick guide to ECGs

At a glance: The STEP trials